Wedgewood Pharmacy honored by N.J. business association
SWEDESBORO, N.J. — The New Jersey Business & Industry Association has recognized Wedgewood Pharmacy, a one of the largest compounding pharmacies in the country according to the company, with its annual Award for Excellence, in the organization’s Business Success category.
The award is given annually to a business that has shown exceptional business growth, and since 2012, Wedgewood Pharmacy has seen a 44% growth in the number of its employees.
“Although we are a relatively small company, our ability to deploy significant technology improvements and process improvements using best-in-class change-management principles is crucial,” Wedgewood Pharmacy CEO Lucy Malmberg said. “We believe these skill sets enable us to compete and grow in a dynamic industry and are useful tools in optimizing our ability to serve the needs of patients and prescribers.”
The company has 266 employees and has a 40,000-sq. ft. prescription and order intake department in addition to a laboratory and pharmacy dispensary. The company compounds prescriptions for 30,000 prescribers and patients.
“Our primary goal is to serve our patients,” Malmberg said. “We recognized that with our growth we had to develop processes that assured high quality and prompt delivery to our customers. We’re grateful that NJBIA has acknowledged our pharmacy and our dedicated people.”
Sandoz introduces generic Lescol XL
PRINCETON, N.J. — Sandoz on Friday announced that it had launched its generic version of Novartis’ Lescol XL (fluvastatin) extended-release tablets. The drug is indicated to treat high cholesterol alongside diet and exercise.
“Sandoz is committed to expanding our portfolio of affordable, high-quality treatment options for US patients,” said Peter Goldschmidt, President of Sandoz Inc. “We are pleased to work with our Novartis Pharmaceuticals Corporation colleagues to offer an authorized generic version of Lescol XL to the tens of millions of Americans trying to control their cholesterol.”
The fluvastatin tablets will be available in 80-mg dosage strength. Lescol XL had U.S. sales of about $36 million for the 12 months ending August 2015.
Greenstone launches authorized generic of Zarontin
PEAPACK, N.J. — Greenstone announced this week that it had introduced its authorized generic of Zarontin (ethosuximide) capsules and oral solution. Ethosuximide is indicated to treat seizures in patients with epilepsy.
The capsules will be available in 250-mg dosage strength and sold in 100-count bottles. The oral solution will be available in 250 mg/5 mL strength.
The authorized generic adds to Greenstone’s growing line of products whose distribution and customer support are backed by Pfizer.